Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors.

Masahiko Hayakawa; Hiroyuki Kaizawa; Hiroyuki Moritomo; Tomonobu Koizumi; Takahide Ohishi; Minoru Okada; Mitsuaki Ohta; Shin-ichi Tsukamoto; Peter Parker; Paul Workman

doi:10.1016/j.bmc.2006.06.046

Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors.

Identifier:nobleid.org/w1/20260515/116AF9BC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/116AF9BC.svg?ark=w1%2F20260515%2F116AF9BC)](https://nobleid.org/work/w1/20260515/116AF9BC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors.

Identifier:nobleid.org/w1/20260515/116AF9BC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/116AF9BC.svg?ark=w1%2F20260515%2F116AF9BC)](https://nobleid.org/work/w1/20260515/116AF9BC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work